Pericarpium trichosanthis injection combined with conventional western medicine for angina pectoris: a meta-analysis

Chengyu LI,Xiaoyu ZHANG,Xiaoyi TANG,Min LI,Xinyu YANG,Hongcai SHANG
DOI: https://doi.org/10.7507/1672-2531.201703032
2017-01-01
Abstract:Objective To systematically review the efficacy and safety of pericarpium trichosanthis injection combined with conventional western medicine for angina pectoris.Methods Databases including CBM,CNKI,WanFang Data,VIP,PubMed,The Cochrane Library and Web of Science were searched from inception to February 20th 2017 to collect randomized controlled trials (RCTs) about pericarpium trichosanthis injection combined with conventional western medicine for angina pectoris.Two reviewers independently screened literature,extracted data and assessed the risk of bias of included studies.Then,meta-analysis was performed using RevMan 5.3 software.Results A total of 10 RCTs involving 1 004 patients were included.The results of meta-analysis showed that:the effective rate of angina symptoms (RR=1.24,95%CI 1.15 to 1.33,P<0.000 01) and resting ECG (RR=1.30,95%CI 1.15 to 1.45,P<0.000 1)in pericarpium trichosanthis injection combined with conventional western medicine group were superior to the conventional western medicine group.And the adverse reaction was rare and could be more tolerated in pericarpium trichosanthis injection combined with conventional western medicine group.Conclusion Pericarpium trichosanthis injection combined with conventional western medicine can improve the symptoms of angina pectoris and objective indicator of ECG.However,due to the low quality of included studies and lack of evidence,the above results are needed to be validated by further well-designed multicenter,large scale,double blind RCTs.
What problem does this paper attempt to address?